Literature DB >> 8107258

gp120-independent fusion mediated by the human immunodeficiency virus type 1 gp41 envelope glycoprotein: a reassessment.

L Marcon1, J Sodroski.   

Abstract

In a natural context, membrane fusion mediated by the human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins involves both the exterior envelope glycoprotein (gp120) and the transmembrane glycoprotein (gp41). Perez et al. (J. Virol. 66:4134-4143, 1992) reported that a mutant HIV-1 envelope glycoprotein containing only the signal peptide and carboxyl terminus of the gp120 exterior glycoprotein fused to the complete gp41 glycoprotein was properly cleaved and that the resultant gp41 glycoprotein was able to induce the fusion of even CD4-negative cells. In the studies reported herein, mutant proteins identical or similar to those studied by Perez et al. lacked detectable cell fusion activity. The proteolytic processing of these proteins was very inefficient, and one processed product identified by Perez et al. as the authentic gp41 glycoprotein was shown to contain carboxyl-terminal gp120 sequences. Furthermore, no fusion activity was observed for gp41 glycoproteins exposed after shedding of the gp120 glycoprotein by soluble CD4. Thus, evidence supporting a gp120-independent cell fusion activity for the HIV-1 gp41 glycoprotein is currently lacking.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8107258      PMCID: PMC236662     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion.

Authors:  S N Ebata; M J Côté; C Y Kang; K Dimock
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

2.  Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex.

Authors:  B S Stein; E G Engleman
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

3.  Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding.

Authors:  A Cordonnier; Y Rivière; L Montagnier; M Emerman
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  The N-terminal 31 amino acids of human immunodeficiency virus type 1 envelope protein gp120 contain a potential gp41 contact site.

Authors:  M Ivey-Hoyle; R K Clark; M Rosenberg
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.

Authors:  T K Hart; R Kirsh; H Ellens; R W Sweet; D M Lambert; S R Petteway; J Leary; P J Bugelski
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

6.  Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies.

Authors:  J Y Xu; M K Gorny; T Palker; S Karwowska; S Zolla-Pazner
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

7.  Effects on CD4 binding of anti-peptide sera to the fourth and fifth conserved domains of HIV-1 gp120.

Authors:  B Ardman; M Kowalski; J Bristol; W Haseltine; J Sodroski
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

8.  Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  P L Earl; R W Doms; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

9.  Enhancement of SIV infection with soluble receptor molecules.

Authors:  J S Allan; J Strauss; D W Buck
Journal:  Science       Date:  1990-03-02       Impact factor: 47.728

10.  Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.

Authors:  Q J Sattentau; J P Moore
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

View more
  6 in total

1.  The entire SU subunit is required for the incorporation of the HIV-1 envelope glycoprotein complex into virions.

Authors:  Y Y Li; L G Perez
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes.

Authors:  D Lavillette; M Maurice; C Roche; S J Russell; M Sitbon; F L Cosset
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

3.  Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid).

Authors:  H R Choe; J Sodroski
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

4.  The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells.

Authors:  R Lodge; H Göttlinger; D Gabuzda; E A Cohen; G Lemay
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

5.  Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.

Authors:  R Wyatt; J Moore; M Accola; E Desjardin; J Robinson; J Sodroski
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

6.  Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1.

Authors:  P J Klasse; J P Moore
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.